Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1999
11/10/1999EP0954303A2 Methods of treating mental diseases, inflammation and pain
11/10/1999EP0954302A1 Therapeutic methods and compositions involving isoflavones
11/10/1999EP0954301A1 Methods for providing safe local anesthesia
11/10/1999EP0954300A2 Prophylactic and therapeutic treatment of skin sensitization and irritation
11/10/1999EP0954299A1 Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
11/10/1999EP0954298A1 Utilisation des derives 2,5-dihydroxybenzenesulfoniques pour la fabrication de medicaments destines a la normalisation de la fonction endotheliale, pour le traitement de la dysfonction sexuelle et des complications vasculaires du diabete, ainsi que des troubles vasculaires d'origine endotheliale
11/10/1999EP0954297A1 Use of bisphenolic compounds to treat type ii diabetes
11/10/1999EP0954296A1 Use of bronopol for the treatment of diseases in fish
11/10/1999EP0954295A1 Methods of cancer treatment using naaladase inhibitors
11/10/1999EP0954294A1 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds
11/10/1999EP0954292A1 Pharmaceutical formulations with delayed drug release
11/10/1999EP0954289A1 Disinfectant effervescent tablet formulation
11/10/1999EP0954288A1 Solid solution of an antifungal agent with enhanced bioavailability
11/10/1999EP0954285A1 Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
11/10/1999EP0954284A1 Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability
11/10/1999EP0954283A2 Formulation and method for treating neoplasms by inhalation
11/10/1999EP0954282A1 Preparation of particles for inhalation
11/10/1999EP0954281A1 Moistening preparation
11/10/1999EP0954278A1 Pharmaceutical compositions containing kukui nut oil
11/10/1999EP0954277A1 Cosmetic self-tanning agent having a sunscreen effect
11/10/1999EP0954274A1 Topical product formulations containing strontium for reducing skin irritation
11/10/1999EP0954222A1 Gene therapy for proliferative vitreoretinopathy
11/10/1999EP0863873B1 Indole carbamates as leukotriene antagonists
11/10/1999EP0776208B1 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
11/10/1999EP0773949B1 D-mannose or xylitol esters and their use as drugs
11/10/1999EP0766691B1 Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
11/10/1999EP0741737B1 Watersoluble azole antifungals
11/10/1999EP0662961B1 Process of synthesizing useful intermediates of substituted imidazole compounds
11/10/1999EP0635026B1 Novel lipophilic oligopeptides with immunomodulating activity
11/10/1999EP0610487B1 New aminoacid derivates, process for producing the same and pharmaceutical compositions containing these compounds
11/10/1999EP0579784B1 Method for preventing restenosis following reconfiguration of body vessels
11/10/1999EP0547165B1 Process for the Preparation of Water-Soluble Camptothecin Analogues, as well as the compounds 10-Hydroxy-11-C(1-6)-alkoxycamptothecin
11/10/1999EP0544906B1 Antibacterial penem esters derivatives
11/10/1999EP0531447B1 Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna
11/10/1999CN1234836A Retroviral vectors
11/10/1999CN1234803A N heterocyclic substituted adenosine derivatives
11/10/1999CN1234802A Intermediates and process for preparing olanzapine
11/10/1999CN1234801A 3-methylamide derivatives of 5H-pyrrolo [2,1,-C] [1,4]-benzodiazepines
11/10/1999CN1234800A Naphthyridine derivatives
11/10/1999CN1234799A 1,4-disubstituted piperazines
11/10/1999CN1234798A Benzamidine derivatives substituted by cyclic amino acid or cyclic hydroxy acid derivatives and their use as anti-coagulants
11/10/1999CN1234797A N-substituted azaheterocyclic compound
11/10/1999CN1234795A Heterocyclic esters and amides chemical compounds
11/10/1999CN1234792A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases
11/10/1999CN1234791A Inhibition of matrix metalloproteases by 2-('omega'-aroylalkyl)-4-biaryl-oxobutyric acids
11/10/1999CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same
11/10/1999CN1234739A Crystalline pharmaceutical product
11/10/1999CN1234738A 奥氮平二水合物d Olanzapine dihydrate d
11/10/1999CN1234737A Pharmaceutical compositions containing S-alkylisothiouronium derivatives
11/10/1999CN1234736A Preparation for transport of active substance across barriers
11/10/1999CN1234406A Single-chain multiple antigen-binding molecule, its preparation and use
11/10/1999CN1234398A Process for preparing alpha-adrenergic aceptor antagonist
11/10/1999CN1234397A Compounds of carbostyrils and their preparation and use
11/10/1999CN1234396A Process for alkylation of hindered sulfamide
11/10/1999CN1234239A Sprayed powder for treating macerative erosive beriberi
11/10/1999CN1234234A Sports drinking
11/10/1999CN1234233A Solid dispersion of Lamola azole
11/10/1999CN1234232A External-use medicine composition for treating angioma and preparation method thereof
11/10/1999CN1234229A Apparatus for treatment of immunomediated inflammatory disorders
11/10/1999CN1046290C Process of preparing etoposide phosphate and etoposide
11/10/1999CN1046288C Unsaturated phosphonates derivatives of purines
11/10/1999CN1046287C Substituted propane-2-OL derivatives, preparation method and fungicidal composition thereof containing same
11/10/1999CN1046285C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
11/10/1999CN1046283C Process for preparation of 9-amino camptothecin
11/10/1999CN1046281C Pharmacologically active enantiomers and preparation method thereof
11/10/1999CN1046277C Quinoline derivative, preparing method and use thereof
11/10/1999CN1046276C Easters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones and use thereof
11/10/1999CN1046274C Isoxazoline compounds as antinflammatory agents
11/10/1999CN1046273C 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-diazoles useful as memory enhancers
11/10/1999CN1046271C Substituted pyrimidines and fungicidal and pesticidal and anti-septic composition containing same
11/10/1999CN1046270C Pyrimidine-thloalkyl and alkylether compounds
11/10/1999CN1046269C HIV protease inhibitors
11/10/1999CN1046268C Dihydro-indolin-2-one derivative
11/10/1999CN1046202C Preparation method for improved freeze dried isocyclophosphamide composition
11/10/1999CN1046201C Capsule for treatment of spasm
11/10/1999CN1046200C Inflammation diminishing and pain easing plaster and making method therefor
11/10/1999CN1046199C Compound fine-powder preparation for diminishing inflammation and relieving pain
11/09/1999US5981826 Poly(vinyl alcohol) cryogel
11/09/1999US5981821 Dressing product with a calcium alginate matrix and method of production of the same
11/09/1999US5981791 High purity N-(4-[N,N-bis(2-iodoethyl)amino]phenoscycarbonyl)-L-glutamic acid
11/09/1999US5981780 In vivo calcium transport as well as bone calcium mobilization activity, treatment of osteoporosis, possible use in the treatment of cancerous diseases
11/09/1999US5981777 Recovery of taxanes from plant material
11/09/1999US5981776 Heterocyclic biaryl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
11/09/1999US5981774 Preparing 3,5-di(2,3-epoxypropoxy)-1-hydroxyxanthone by reacting 1,3,5-trimethoxyxanthone with hydrogen iodide in phenol whereby 1,3,5-trihydroxyxanthone is obtained, reacting product with epichlorohydrin in potassium hydroxide
11/09/1999US5981767 Method of producing dry thioctic acid
11/09/1999US5981765 For treatment of post-menopausal syndrome including osteoporosis, cardiovascular effects such as hyperlipidemia, and estrogen-dependent cancer, particularly breast and uterine cancer
11/09/1999US5981762 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors
11/09/1999US5981755 Tachykinin antagonists
11/09/1999US5981754 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity
11/09/1999US5981753 Reacting a naphthalic anhydride with a polyamine and a second naphthalic anhydride
11/09/1999US5981751 Method for removal of residual organic solvents and use thereof in manufacturing pharmaceuticals
11/09/1999US5981744 Removing an 11-alpha leaving group from starting compound to generate a double bond between the 9- and 11-carbon atoms
11/09/1999US5981731 Anticarcinogenic/antitumor/antiproliferative agents and diagnostic agents targeted against gene which codes for a protein kinase involved in signal transduction
11/09/1999US5981717 Mammalian tolloid-like gene and protein
11/09/1999US5981712 Antibody which binds to carboxyamido-triazole resistance protein; for detecting resistance to drug which prevents calcium influx in biological samples/cells
11/09/1999US5981693 Process for removing bile salts from a patient and alkylated compositions therefor
11/09/1999US5981605 Containing more than 90% of a drying and/or protein coagulating, short-chained alcohol or alcohol mixture, primarily ethanol, and gelling agent; good skin-adhesive properties, matrix formation, forms a protective coating
11/09/1999US5981604 Materials and methods for inhibiting bacterial cell wall biosynthesis
11/09/1999US5981603 Antiviral agents
11/09/1999US5981602 Ajoene inhibits the growth of hiv-infected cells, hiv, and other viruses, also inhibits the incorporation of hiv into cd4-negative cells
1 ... 6415 6416 6417 6418 6419 6420 6421 6422 6423 6424 6425 6426 6427 6428 6429 6430 6431 6432 6433 6434 6435 ... 7860